Abstract
The Veterans ECS21 (Exploring Cannabigerol for Sleep) Study is the first clinical trial of Cannabigerol (CBG), a non-psychoactive cannabinoid (ClinicalTrials.gov Identifier: NCT05088018). This study investigates if CBG improves sleep for U.S. Veterans in California using a fully remote (decentralized), randomized, placebo-controlled, triple-blind, pre–post study design. Over 100 participants will be recruited through Veterans advocacy organizations, email campaigns, and point-of-sale displays at cannabis dispensaries. Participants will be provided with a study application to assess sleep quality, quality of life, and PTSD-related symptoms. A Fitbit Inspire 2 will be used to collect sleep, activity, and cardiovascular biometrics. After a two-week run-in phase, participants will begin a four-week treatment phase with a dose escalation from 25 mg daily CBG (CBG Protab™ by LEVEL) up to 50 mg CBG daily. The present paper describes how we designed this study to overcome specific challenges. We held participant insight panels to learn Veterans’ lived experience and design ways to lower their obstacles to clinical research participation. We designed digital engagement strategies to maintain high participation and retention for a fully remote (decentralized) study, selected fit-for-purpose passive data collection mechanisms, and addressed common reproducibility issues in cannabis research.
Competing Interest Statement
C.R.E. is an employee, shareholder, and fiduciary officer of Metta Medical (dba LEVEL). C.E.W. is an employee of nymbly, which was contracted by Metta Medical (dba LEVEL) for the conduct of this study. E.J.D. is an employee of Stats-of-1 which was contracted by Metta Medical (dba LEVEL) for the conduct of this study. No other potential conflicts of interest relevant to this article are reported.
Clinical Trial
NCT05088018
Funding Statement
This study and costs associated with development of this manuscript were supported by Metta Medical (dba LEVEL).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Advarra gave ethical approval for this work (Advarra; Pro00056526)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Author ORCIDs and emails.
Chris R Emerson Email: chris{at}levelexperience.com
Courtney E Webster Email: courtney{at}nymbly.work
EJ Daza Email: ericjdaza{at}statsof1.org
Funding source: This study and costs associated with development of this manuscript were supported by Metta Medical (dba LEVEL).
Conflict of interest: C.R.E. is an employee, shareholder, and fiduciary officer of Metta Medical (dba LEVEL). C.E.W. is an employee of nymbly, which was contracted by Metta Medical (dba LEVEL) for the conduct of this study. E.J.D. is an employee of Stats-of-1 which was contracted by Metta Medical (dba LEVEL) for the conduct of this study. No other potential conflicts of interest relevant to this article are reported.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
